Metabolic dysfunction-associated steatotic liver disease — USMLE Step 3 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Titrate atropine to clear bronchial secretions and administer pralidoxime early
The best answer is “Titrate atropine to clear bronchial secretions and administer pralidoxime early”. Atropine is rapidly repeated and escalated to the clinical endpoint of drying bronchial secretions and improving oxygenation and ventilation, not normalization of pupils or heart rate. Pralidoxime is added early to reactivate acetylcholinesterase before aging and helps nicotinic weakness. Physostigmine intensifies toxicity, and epinephrine does not reverse the cholinergic syndrome.
Reference: ATSDR Medical Management Guideline: Parathion: https://wwwn.cdc.gov/TSP/MMG/MMGDetails.aspx?mmgid=1140&toxid=246